FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine. A method for evaluating the cytoprotective effect (CPE) of intravenous immunoglobulin preparations (IVIGP) against trophoblast cells under conditions of their interaction with natural killers is proposed. A culture of trophoblast cells is used, some of which are incubated without mononuclear cells, some in the presence of monoculars, and some in the presence of IVIGP preparation at a concentration of 6 mg/ml. The number of non-viable trophoblast cells is determined. The coefficient of the cytoprotective effect of IVIGP preparations in relation to trophoblast cells is calculated. With CPE <1, a positive cytoprotective effect is predicted. With CPE ≥1, there is no cytoprotective effect.
EFFECT: invention allows evaluating the effectiveness of CPE of IVIGP preparation in relation to trophoblast cells in vitro in the presence of peripheral blood NK cells.
1 cl, 4 dwg, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR NK-CELLS CYTOTOXIC ACTIVITY DETERMINATION | 2016 |
|
RU2632109C1 |
METHOD OF ASSESSING THE RISK OF NON-PREGNANCY IN WOMEN WITH USUAL MISCARRIAGE | 2017 |
|
RU2657433C1 |
METHOD FOR PREDICTING CYTOPROTECTIVE EFFECT OF IMMUNOGLOBULINS FOR INTRAVENOUS ADMINISTRATION IN THERAPY OF FEMALES WITH RECURRENT PREGNANCY LOSS AND DIAGNOSED ANTI-PHOSPHOLIPID SYNDROME | 2014 |
|
RU2548754C1 |
METHOD FOR ACTIVATION OF CYTOTOXIC LYMPHOCYTES | 2019 |
|
RU2751837C2 |
METHOD FOR PRODUCING ACTIVATED LEUKOCYTES FOR ADJUVANT ADOPTIVE IMMUNOTHERAPY OF MALIGNANT GROWTHS | 2009 |
|
RU2414915C2 |
METHOD OF STIMULATING FETAL WEIGHT IN THE EARLY STAGES OF PREGNANCY IN EXPERIMENT | 2018 |
|
RU2675354C1 |
AGENT INDUCING HEMOPOIETIC STEM CELL DIFFERENTIATION INTO THROMBOCYTES | 2012 |
|
RU2482870C1 |
METHOD FOR IMMUNOGENICITY TESTING OF VACCINE ANTIGENS FOR PRODUCING HIGHLY EFFECTIVE VACCINES AGAINST DANGEROUS INFECTIONS | 2018 |
|
RU2722648C2 |
Bifidobacterium longum STRAIN, SUITABLE FOR APPLICATION IN IMMUNOMODULATION, INDUCTION OF CYTOKINS PRODUCTION, TREATMENT OF AUTOIMMUNE DISEASE, CONTROL OF IL - 10:IL - 12 RATIO, AND APPLICATION THEREOF | 2010 |
|
RU2557310C2 |
AGENT POSSESSING APOPTOSIS-INHIBITING ACTIVITY | 2018 |
|
RU2677877C1 |
Authors
Dates
2022-03-24—Published
2021-07-13—Filed